Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Q33274572)

25 July 2017

title

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (English)

1 reference

25 July 2017

author name string

ESMO / European Sarcoma Network Working Group

series ordinal

1

1 reference

25 July 2017

publication date

1 October 2012

1 reference

25 July 2017

1 reference

25 July 2017

volume

23 Suppl 7

1 reference

25 July 2017

page(s)

vii100-9

1 reference

Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Incidence of biopsy-proven bone tumors in children: a report based on the Dutch pathology registration "PALGA".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

The final diagnosis in patients with a suspected primary malignancy of bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Earlier diagnosis of bone and soft-tissue tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Results of diagnostic review in pediatric bone tumors and tumorlike lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Utilization of positron emission tomography in the management of patients with sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Prognostic factors in localized extremity osteosarcoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Ewing sarcoma: prognostic criteria, outcomes and future treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Common musculoskeletal tumors of childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Current strategies of chemotherapy in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Delaying surgery with chemotherapy for osteosarcoma of the extremities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

The role of interferons in the treatment of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Complexities in interpretation of osteosarcoma clinical trial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Osteosarcoma over the age of forty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Periosteal osteosarcoma--a European review of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Periosteal osteosarcoma: a single-institution experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Chromosome study of Ewing's sarcoma (ES) cell lines. Consistency of a reciprocal translocation t(11;22)(q24;q12).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Treatment strategies for metastatic Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Ewing's sarcoma family of tumors: current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Imaging evaluation of the response of high-grade osteosarcoma and Ewing sarcoma to chemotherapy with emphasis on dynamic contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

The clinical approach towards chondrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

The clinical management of chondrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Radiotherapeutic factors in the management of cervical-basal chordomas and chondrosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Chordoma of the mobile spine: fifty years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Results of carbon ion radiotherapy in 152 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS254

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS254

1 reference

25 July 2017

1 reference